FDA Inspection 1323162 — Avara Liscate Pharmaceutical Services SPA
The FDA completed an inspection of Avara Liscate Pharmaceutical Services SPA on Feb 20, 2026 in Liscate. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Feb 20, 2026
- Fiscal Year
- 2026
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Liscate (Italy)
Additional details
Mutual Recognition Agreement (MRA)